Episode 253 - Innovators Revisited - Expanding treatment for complex neurodegenerative diseases - Howard Berman of Coya Therapeutics

Today, we are looking back a conversation I had last year with Howard Berman, co-founder and CEO of Coya Therapeutics, which has had quite the busy summer. The company expanded its collaboration with Houston Methodist Research Institute and started looking into how GLP-1 drugs  can enhance the effects of its proprietary therapeutics.

Read more about these two news stories from this summer on InnovationMap: